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Introduction Neuropathic pain is serious and its treatment
difﬁcult. Treatment is efﬁcient, when quality of life is increased [1].
Objective To determine the frequency of neuropathic pain at the
National Centre of Orthopaedic Equipment, Dakar, Senegal and to
study the difﬁculties of management of neuropathic pain
according to international guidelines.
Methodology A prospective study was undergone in the National
Centre of Orthopaedic Equipment in Dakar, Senegal. Study took
place from October 2014 to January 2015. Patients with pain over
one month answered the neuropathic pain questionnaire and
those with over 4 points were enrolled. Pain intensity was
evaluated with Visual Analogic Scale, motor function with Medical
Research Council Test. Major function (prehension, work, daily
activity, professional activity and sleep) were appreciated. We
veriﬁed the conformity of complementary exams. Evaluation was
done before treatment, three weeks and two months after.
Treatment was based on international guidelines.
Results Forty-three patients suffered neuropathic pain. The sex-
ratio was 0.96. The mean age was 52.22. The mean score of Visual
Analogic Scale was 5.75. Working was difﬁcult (33.96%), impossi-
ble (4 cases), and up and down stair climbing impossible (18.83%).
Among the patients 18.86% could not walk more than 1000meters
and 13.20% of patients could not pick something up. Professional
activity was stopped in 2 cases. Sleep disorders were noted in
33.96%. Complementary exams were done in 54.71% and 9.43%
were not compliant with international guidelines. Most of the
patients received Amitryptiline (54. 71%) and adverse effects were
noted only in 3 cases. With a twomonths follow-up, dimensions of
quality of life were improved in 94.53% of cases.
Discussion and Conclusion Treatment of neuropathic pain im-
proved quality of life. In African country, the choice of molecule
must take into account its efﬁcacy and its accessibility. Rehabili-
tation is important in management of neuropathic pain. It
increases function and improves quality of life. The unnecessary
complementary exams increase the cost, and general practitioners
need a speciﬁc piece of information about the neuropathic pain and
its treatment.
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